Yano Y - Search Results

1

Significance of post-progression therapy after tyrosine kinase inhibitors for advanced hepatocellular carcinoma.

Yano Y, Yamamoto A, Minami A, Momose K, Mimura T, Kim SK, Hayashi H, Kado T, Hirano H, Hirohata S, Yoon S, Nishi K, Tei H, Tanaka H, Oouchi S, Matsuura T, Yasutomi E, Hatazawa Y, Shiomi Y, Ueda Y, Kodama Y; Kobe Liver Conference (KLC). Yano Y, et al. JGH Open. 2022 May 25;6(6):427-433. doi: 10.1002/jgh3.12772. eCollection 2022 Jun. JGH Open. 2022. PMID: 35774348 Free PMC article.

2

Unplanned hemodialysis initiation and low geriatric nutritional risk index scores are associated with end-stage renal disease outcomes.

Maenosono R, Fukushima T, Kobayashi D, Matsunaga T, Yano Y, Taniguchi S, Fujiwara Y, Komura K, Uehara H, Kagitani M, Hirano H, Inamoto T, Nomi H, Azuma H. Maenosono R, et al. Among authors: yano y. Sci Rep. 2022 Jun 30;12(1):11101. doi: 10.1038/s41598-022-14123-y. Sci Rep. 2022. PMID: 35773447 Free PMC article.

3

Influence of Discontinuation of Cardiac Rehabilitation in Elderly Outpatients Due to the COVID-19 Pandemic.

Mouri N, Suematsu Y, Yano Y, Morita K, Shirosaki M, Fujita M, Matsuda T, Matsuo S, Tazawa R, Fujimi K, Miura SI. Mouri N, et al. Among authors: yano y. J Cardiovasc Dev Dis. 2022 Jun 18;9(6):194. doi: 10.3390/jcdd9060194. J Cardiovasc Dev Dis. 2022. PMID: 35735824 Free PMC article.

4

White-coat effect on orthostatic hypotension: a nationwide survey of Japanese general practitioners.

Yuasa S, Yamamoto H, Suzuki Y, Chin K, Ukai H, Kobayashi Y, Yano Y, Mori H. Yuasa S, et al. Among authors: yano y. Blood Press Monit. 2022 Jun 10. doi: 10.1097/MBP.0000000000000605. Online ahead of print. Blood Press Monit. 2022. PMID: 35687032

5

Multicomponent Crystals with Competing Intermolecular Interactions: In Situ X-ray Diffraction and Luminescent Features Reveal Multimolecular Assembly of Mechanochemical Conditions.

Yano Y, Kasai H, Zheng Y, Nishibori E, Hisaeda Y, Ono T. Yano Y, et al. Angew Chem Int Ed Engl. 2022 Jun 10. doi: 10.1002/anie.202203853. Online ahead of print. Angew Chem Int Ed Engl. 2022. PMID: 35686971

6

Association of Cardiovascular Health Metrics with Risk of Transition to Hypertension in Non-Hypertensive Young Adults.

Suzuki Y, Kaneko H, Yano Y, Okada A, Itoh H, Matsuoka S, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Matsunaga A, Node K, McEvoy JW, Lam CSP, Oparil S, Yasunaga H, Komuro I. Suzuki Y, et al. Among authors: yano y. Am J Hypertens. 2022 May 25:hpac057. doi: 10.1093/ajh/hpac057. Online ahead of print. Am J Hypertens. 2022. PMID: 35639507

7

Antihypertensive drugs and cancer risk.

Kidoguchi S, Sugano N, Yokoo T, Kaneko H, Akazawa H, Mukai M, Node K, Yano Y, Nishiyama A; Japanese Society of Hypertension (JSH) working group “Onco-Hypertension”. Kidoguchi S, et al. Among authors: yano y. Am J Hypertens. 2022 May 20:hpac066. doi: 10.1093/ajh/hpac066. Online ahead of print. Am J Hypertens. 2022. PMID: 35595533

8

Medication Naïve Blood Pressure and Incident Cancers: Analysis of Two Nationwide Population-Based Databases.

Kaneko H, Yano Y, Lee HH, Lee H, Okada A, Itoh H, Morita K, Fukui A, Fujiu K, Suzuki Y, Matsuoka S, Nakamura S, Michihata N, Jo T, Takeda N, Morita H, Yokoo T, Nishiyama A, Node K, Viera AJ, Muntner P, Oparil S, Kim HC, Yasunaga H, Komuro I. Kaneko H, et al. Among authors: yano y. Am J Hypertens. 2022 May 4:hpac054. doi: 10.1093/ajh/hpac054. Online ahead of print. Am J Hypertens. 2022. PMID: 35512273

9

Fundamental Care's state of knowledge around the world: Where are we now? A scoping review.

Savoie C, Rey S, Yokota S, Dallaire C, Kimura S, Takatani S, Yano Y. Savoie C, et al. Among authors: yano y. J Adv Nurs. 2022 May 5. doi: 10.1111/jan.15278. Online ahead of print. J Adv Nurs. 2022. PMID: 35511714 Review.

10

Alternating therapy with osimertinib and afatinib for treatment-naive patients with EGFR-mutated advanced non-small cell lung cancer: A single-group, open-label phase 2 trial (WJOG10818L).

Hayashi H, Yonesaka K, Nakamura A, Fujimoto D, Azuma K, Sakata S, Tachihara M, Ikeda S, Yokoyama T, Hataji O, Yano Y, Hirano K, Daga H, Okada H, Chiba Y, Sakai K, Nishio K, Yamamoto N, Nakagawa K. Hayashi H, et al. Among authors: yano y. Lung Cancer. 2022 Jun;168:38-45. doi: 10.1016/j.lungcan.2022.04.004. Epub 2022 Apr 12. Lung Cancer. 2022. PMID: 35477147 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results